The risk of type 2 oral polio vaccine use in post-cessation outbreak response

BACKGROUND: Wild type 2 poliovirus was last observed in 1999. The Sabin-strain oral polio vaccine type 2 (OPV2) was critical to eradication, but it is known to revert to a neurovirulent phenotype, causing vaccine-associated paralytic poliomyelitis. OPV2 is also transmissible and can establish circul...

Descripción completa

Detalles Bibliográficos
Autores principales: McCarthy, Kevin A., Chabot-Couture, Guillaume, Famulare, Michael, Lyons, Hil M., Mercer, Laina D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627419/
https://www.ncbi.nlm.nih.gov/pubmed/28974220
http://dx.doi.org/10.1186/s12916-017-0937-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627419/
https://www.ncbi.nlm.nih.gov/pubmed/28974220
http://dx.doi.org/10.1186/s12916-017-0937-y

Ejemplares similares